UBS AM’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-92,700
| Closed | -$389K | – | 2760 |
|
|
2023
Q2 | $389K | Hold |
92,700
| – | – | ﹤0.01% | 2397 |
|
|
2023
Q1 | $389K | Buy |
92,700
+17,000
| +22% | +$71.4K | ﹤0.01% | 2397 |
|
|
2022
Q4 | $455K | Buy |
+75,700
| New | +$455K | ﹤0.01% | 2206 |
|
|
2016
Q2 | – | Sell |
-11,290
| Closed | -$60K | – | 2681 |
|
|
2016
Q1 | $60K | Hold |
11,290
| – | – | ﹤0.01% | 2606 |
|
|
2015
Q4 | $139K | Buy |
11,290
+1,870
| +20% | +$23K | ﹤0.01% | 2622 |
|
|
2015
Q3 | $138K | Hold |
9,420
| – | – | ﹤0.01% | 2565 |
|
|
2015
Q2 | $184K | Hold |
9,420
| – | – | ﹤0.01% | 2604 |
|
|
2015
Q1 | $171K | Hold |
9,420
| – | – | ﹤0.01% | 2519 |
|
|
2014
Q4 | $222K | Hold |
9,420
| – | – | ﹤0.01% | 2422 |
|
|
2014
Q3 | $228K | Buy |
9,420
+5,020
| +114% | +$122K | ﹤0.01% | 2305 |
|
|
2014
Q2 | $124K | Buy |
+4,400
| New | +$124K | ﹤0.01% | 2505 |
|